Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in PLoS Pathog Retrieve available abstracts of 125 articles: HTML format

Single Articles

April 2024
1. KEELE BF, Okoye AA, Fennessey CM, Varco-Merth B, et al
   Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
   PLoS Pathog. 2024;20:e1012135.
   PubMed     Abstract available
   
   
   
2. WONG RW, Balachandran A, Cheung PK, Cheng R, et al
   Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
   PLoS Pathog. 2024;20:e1012155.
   PubMed     Abstract available
   
   
   March 2024
3. LAYISH B, Goli R, Flick H, Huang SW, et al
   Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
   PLoS Pathog. 2024;20:e1011830.
   PubMed     Abstract available
   
   
   
4. ZHANG X, Hu Y, Vandenhoudt RE, Yan C, et al
   Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts.
   PLoS Pathog. 2024;20:e1012063.
   PubMed     Abstract available
   
   
   February 2024
5. JOSEPH SB, Abrahams MR, Moeser M, Tyers L, et al
   The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
   PLoS Pathog. 2024;20:e1011974.
   PubMed     Abstract available
   
   
   
6. SUMNER C, Ono A
   The "basics" of HIV-1 assembly.
   PLoS Pathog. 2024;20:e1011937.
   PubMed    
   
   
   
7. BENNETT SJ, Yalcin D, Privatt SR, Ngalamika O, et al
   Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.
   PLoS Pathog. 2024;20:e1012023.
   PubMed     Abstract available
   
   
   January 2024
8. GRUNST MW, Gil HM, Grandea AG 3rd, Snow BJ, et al
   Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.
   PLoS Pathog. 2024;20:e1011819.
   PubMed     Abstract available
   
   
   
9. SALAS-BRICENO K, Zhao W, Ross SR
   Murine leukemia virus infection of non-dividing dendritic cells is dependent on nucleoporins.
   PLoS Pathog. 2024;20:e1011640.
   PubMed     Abstract available
   
   
   
10. MORALES AE, Gumenick R, Genovese CM, Jang YY, et al
    Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
    PLoS Pathog. 2024;20:e1011881.
    PubMed     Abstract available
    
    
    December 2023
11. ZHOU Y, Jadlowsky J, Baiduc C, Klattenhoff AW, et al
    Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells.
    PLoS Pathog. 2023;19:e1011853.
    PubMed     Abstract available
    
    
    
12. VAN RYK D, Vimonpatranon S, Hiatt J, Ganesan S, et al
    The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ?4beta7.
    PLoS Pathog. 2023;19:e1011860.
    PubMed     Abstract available
    
    
    
13. ELIZALDI SR, Verma A, Ma ZM, Ott S, et al
    Deep analysis of CD4 T cells in the rhesus CNS during SIV infection.
    PLoS Pathog. 2023;19:e1011844.
    PubMed     Abstract available
    
    
    
14. WIECZOREK L, Sanders-Buell E, Zemil M, Lewitus E, et al
    Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
    PLoS Pathog. 2023;19:e1011780.
    PubMed     Abstract available
    
    
    
15. LING L, De C, Spagnuolo RA, Begum N, et al
    Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice.
    PLoS Pathog. 2023;19:e1011824.
    PubMed     Abstract available
    
    
    
16. RUSSELL ML, Fish CS, Drescher S, Cassidy NAJ, et al
    Using viral sequence diversity to estimate time of HIV infection in infants.
    PLoS Pathog. 2023;19:e1011861.
    PubMed     Abstract available
    
    
    November 2023
17. DWIVEDI AK, Gornalusse GG, Siegel DA, Barbehenn A, et al
    A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
    PLoS Pathog. 2023;19:e1011114.
    PubMed     Abstract available
    
    
    
18. MOYO-GWETE T, Richardson SI, Keeton R, Hermanus T, et al
    Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
    PLoS Pathog. 2023;19:e1011772.
    PubMed     Abstract available
    
    
    
19. DOCKEN SS, McCormick K, Pampena MB, Samer S, et al
    Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency.
    PLoS Pathog. 2023;19:e1011755.
    PubMed     Abstract available
    
    
    October 2023
20. RINGE RP, Colin P, Ozorowski G, Allen JD, et al
    Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
    PLoS Pathog. 2023;19:e1011601.
    PubMed     Abstract available
    
    
    
21. MOPURI R, Welbourn S, Charles T, Ralli-Jain P, et al
    High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope.
    PLoS Pathog. 2023;19:e1011717.
    PubMed     Abstract available
    
    
    
22. CHANDLER TL, Yang A, Otero CE, Permar SR, et al
    Protective mechanisms of nonneutralizing antiviral antibodies.
    PLoS Pathog. 2023;19:e1011670.
    PubMed     Abstract available
    
    
    
23. PINKEVYCH M, Docken SS, Okoye AA, Fennessey CM, et al
    Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication.
    PLoS Pathog. 2023;19:e1011660.
    PubMed     Abstract available
    
    
    
24. MALYSHKINA A, Bayer W, Podschwadt P, Otto L, et al
    Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles.
    PLoS Pathog. 2023;19:e1011725.
    PubMed     Abstract available
    
    
    September 2023
25. HARWOOD OE, Matschke LM, Moriarty RV, Balgeman AJ, et al
    CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.
    PLoS Pathog. 2023;19:e1011676.
    PubMed     Abstract available
    
    
    
26. SUGAWARA S, Hueber B, Woolley G, Terry K, et al
    Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism.
    PLoS Pathog. 2023;19:e1011629.
    PubMed     Abstract available
    
    
    
27. WONG HT, Luperchio AM, Riley S, Salamango DJ, et al
    Inhibition of ATM-directed antiviral responses by HIV-1 Vif.
    PLoS Pathog. 2023;19:e1011634.
    PubMed     Abstract available
    
    
    August 2023
28. C VIEIRA M, Palm AE, Stamper CT, Tepora ME, et al
    Germline-encoded specificities and the predictability of the B cell response.
    PLoS Pathog. 2023;19:e1011603.
    PubMed     Abstract available
    
    
    
29. LAN J, Wang Y, Yue S, Xu D, et al
    Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
    PLoS Pathog. 2023;19:e1011581.
    PubMed     Abstract available
    
    
    
30. TONG T, D'Addabbo A, Xu J, Chawla H, et al
    Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
    PLoS Pathog. 2023;19:e1011452.
    PubMed     Abstract available
    
    
    July 2023
31. BRUCE JW, Park E, Magnano C, Horswill M, et al
    HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B.
    PLoS Pathog. 2023;19:e1011492.
    PubMed     Abstract available
    
    
    
32. BAUER A, Lindemuth E, Marino FE, Krause R, et al
    Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques.
    PLoS Pathog. 2023;19:e1011059.
    PubMed     Abstract available
    
    
    June 2023
33. MKHIZE NN, Yssel A, Kaldine H, van Dorsten RT, et al
    Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
    PLoS Pathog. 2023;19:e1011469.
    PubMed     Abstract available
    
    
    
34. MADLALA P, Mkhize Z, Naicker S, Khathi SP, et al
    Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
    PLoS Pathog. 2023;19:e1011194.
    PubMed     Abstract available
    
    
    
35. SOWD GA, Shi J, Fulmer A, Aiken C, et al
    HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes.
    PLoS Pathog. 2023;19:e1011423.
    PubMed     Abstract available
    
    
    
36. JOYCE C, Murrell S, Murrell B, Omorodion O, et al
    Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.
    PLoS Pathog. 2023;19:e1011416.
    PubMed     Abstract available
    
    
    May 2023
37. WILLIAMS LD, Shen X, Sawant SS, Akapirat S, et al
    Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
    PLoS Pathog. 2023;19:e1011359.
    PubMed     Abstract available
    
    
    
38. GRUNST MW, Ladd RA, Clark NM, Gil HM, et al
    Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
    PLoS Pathog. 2023;19:e1011407.
    PubMed     Abstract available
    
    
    
39. VAN DOREN VE, Smith SA, Hu YJ, Tharp G, et al
    HIV, asymptomatic STI, and the rectal mucosal immune environment among young men who have sex with men.
    PLoS Pathog. 2023;19:e1011219.
    PubMed     Abstract available
    
    
    
40. POUMBOURIOS P, Langer C, Boo I, Zakir T, et al
    Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core.
    PLoS Pathog. 2023;19:e1010981.
    PubMed     Abstract available
    
    
    
41. SWANSON O, Martin Beem JS, Rhodes B, Wang A, et al
    Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.
    PLoS Pathog. 2023;19:e1011401.
    PubMed     Abstract available
    
    
    
42. ZHANG Z, Bills GF, An Z
    Advances in the treatment of invasive fungal disease.
    PLoS Pathog. 2023;19:e1011322.
    PubMed     Abstract available
    
    
    April 2023
43. ZWYER M, Rutaihwa LK, Windels E, Hella J, et al
    Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania.
    PLoS Pathog. 2023;19:e1010893.
    PubMed     Abstract available
    
    
    
44. DYNESEN LT, Fernandez I, Coquin Y, Delaplace M, et al
    Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.
    PLoS Pathog. 2023;19:e1011339.
    PubMed     Abstract available
    
    
    March 2023
45. BYRNES SJ, Busman-Sahay K, Angelovich TA, Younger S, et al
    Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
    PLoS Pathog. 2023;19:e1011290.
    PubMed     Abstract available
    
    
    
46. ROSINSKI JR, Raasch LE, Barros Tiburcio P, Breitbach ME, et al
    Frequent first-trimester pregnancy loss in rhesus macaques infected with African-lineage Zika virus.
    PLoS Pathog. 2023;19:e1011282.
    PubMed     Abstract available
    
    
    
47. VIMONPATRANON S, Goes LR, Chan A, Licavoli I, et al
    MAdCAM-1 costimulation in the presence of retinoic acid and TGF-beta promotes HIV infection and differentiation of CD4+ T cells into CCR5+ TRM -like cells.
    PLoS Pathog. 2023;19:e1011209.
    PubMed     Abstract available
    
    
    
48. EILERS G, Gupta K, Allen A, Montermoso S, et al
    Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 A resolution: Routes to inhibitor optimization.
    PLoS Pathog. 2023;19:e1011097.
    PubMed     Abstract available
    
    
    
49. TOCCAFONDI E, Kanja M, Winter F, Lener D, et al
    A snapshot on HIV-1 evolution through the identification of phylogenetic-specific properties of HIV-1 integrases M/O.
    PLoS Pathog. 2023;19:e1011207.
    PubMed     Abstract available
    
    
    February 2023
50. YANG Y, Liu S, Luo Y, Wang B, et al
    High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell.
    PLoS Pathog. 2023;19:e1011119.
    PubMed     Abstract available
    
    
    January 2023
51. HSIEH E, Janssens DH, Paddison PJ, Browne EP, et al
    A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency.
    PLoS Pathog. 2023;19:e1011101.
    PubMed     Abstract available
    
    
    
52. TIMILSINA U, Stavrou S
    SERINC5: One antiviral factor to bind them all.
    PLoS Pathog. 2023;19:e1011076.
    PubMed    
    
    
    December 2022
53. ALVES E, Al-Kaabi M, Keane NM, Leary S, et al
    Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains.
    PLoS Pathog. 2022;18:e1010965.
    PubMed     Abstract available
    
    
    November 2022
54. SANTIAGO JC, Adams SV, Towlerton A, Okuku F, et al
    Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates.
    PLoS Pathog. 2022;18:e1010524.
    PubMed     Abstract available
    
    
    
55. SUGRUE E, Wickenhagen A, Mollentze N, Aziz MA, et al
    The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.
    PLoS Pathog. 2022;18:e1010973.
    PubMed     Abstract available
    
    
    
56. VAN SCHOOTEN J, Schorcht A, Farokhi E, Umotoy JC, et al
    Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
    PLoS Pathog. 2022;18:e1010945.
    PubMed     Abstract available
    
    
    
57. SHAHID A, Jones BR, Yang JSW, Dong W, et al
    HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy.
    PLoS Pathog. 2022;18:e1010613.
    PubMed     Abstract available
    
    
    October 2022
58. ZHAO F, Xu F, Liu X, Hu Y, et al
    SERINC5 restricts influenza virus infectivity.
    PLoS Pathog. 2022;18:e1010907.
    PubMed     Abstract available
    
    
    
59. ELMASRI Z, Negi V, Kuhn RJ, Jose J, et al
    Requirement of a functional ion channel for Sindbis virus glycoprotein transport, CPV-II formation, and efficient virus budding.
    PLoS Pathog. 2022;18:e1010892.
    PubMed     Abstract available
    
    
    September 2022
60. GARCIA-KNIGHT M, Anglin K, Tassetto M, Lu S, et al
    Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study.
    PLoS Pathog. 2022;18:e1010802.
    PubMed     Abstract available
    
    
    
61. WHITE JA, Kufera JT, Bachmann N, Dai W, et al
    Measuring the latent reservoir for HIV-1: Quantification bias in near full-length genome sequencing methods.
    PLoS Pathog. 2022;18:e1010845.
    PubMed     Abstract available
    
    
    
62. KARSTEN CB, Bartsch YC, Shin SA, Slein MD, et al
    Evolution of functional antibodies following acute Epstein-Barr virus infection.
    PLoS Pathog. 2022;18:e1010738.
    PubMed     Abstract available
    
    
    
63. SCHEEPERS C, Kgagudi P, Mzindle N, Gray ES, et al
    Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
    PLoS Pathog. 2022;18:e1010450.
    PubMed     Abstract available
    
    
    
64. BOHM RP, Breed MW, Cohen JK, Haertel AJ, et al
    Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021).
    PLoS Pathog. 2022;18:e1010831.
    PubMed    
    
    
    August 2022
65. MORRIS SE, Strehlau R, Shiau S, Abrams EJ, et al
    Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy.
    PLoS Pathog. 2022;18:e1010751.
    PubMed     Abstract available
    
    
    
66. FRANCIS AC, Cereseto A, Singh PK, Shi J, et al
    Localization and functions of native and eGFP-tagged capsid proteins in HIV-1 particles.
    PLoS Pathog. 2022;18:e1010754.
    PubMed     Abstract available
    
    
    
67. JUNG KL, Choi UY, Park A, Foo SS, et al
    Single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection in three-dimensional air-liquid interface culture model.
    PLoS Pathog. 2022;18:e1010775.
    PubMed     Abstract available
    
    
    
68. GUO S, Luke BT, Henry AR, Darko S, et al
    HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy.
    PLoS Pathog. 2022;18:e1010726.
    PubMed     Abstract available
    
    
    July 2022
69. STRONGIN Z, Hoang TN, Tharp GK, Rahmberg AR, et al
    The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence.
    PLoS Pathog. 2022;18:e1010723.
    PubMed     Abstract available
    
    
    
70. MAJERCIAK V, Alvarado-Hernandez B, Lobanov A, Cam M, et al
    Genome-wide regulation of KSHV RNA splicing by viral RNA-binding protein ORF57.
    PLoS Pathog. 2022;18:e1010311.
    PubMed     Abstract available
    
    
    
71. YE F, Alvarez-Carbonell D, Nguyen K, Leskov K, et al
    Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells.
    PLoS Pathog. 2022;18:e1010110.
    PubMed     Abstract available
    
    
    
72. MUNOZ O, Banga R, Schelling R, Procopio FA, et al
    Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.
    PLoS Pathog. 2022;18:e1010673.
    PubMed     Abstract available
    
    
    
73. SIMPSON J, Starke CE, Ortiz AM, Ransier A, et al
    Multiple modes of antigen exposure induce clonotypically diverse epitope-specific CD8+ T cells across multiple tissues in nonhuman primates.
    PLoS Pathog. 2022;18:e1010611.
    PubMed     Abstract available
    
    
    June 2022
74. LAWRENCE SP, Elser SE, Torben W, Blair RV, et al
    A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.
    PLoS Pathog. 2022;18:e1010507.
    PubMed     Abstract available
    
    
    
75. WELLES HC, King HAD, Nettey L, Cavett N, et al
    Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
    PLoS Pathog. 2022;18:e1010574.
    PubMed     Abstract available
    
    
    
76. LINDQVIST B, Jutte BB, Love L, Assi W, et al
    T cell stimulation remodels the latently HIV-1 infected cell population by differential activation of proviral chromatin.
    PLoS Pathog. 2022;18:e1010555.
    PubMed     Abstract available
    
    
    
77. FILES DC, Tacke F, O'Sullivan A, Dorr P, et al
    Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.
    PLoS Pathog. 2022;18:e1010547.
    PubMed     Abstract available
    
    
    
78. FITTJE P, Hoelzemer A, Garcia-Beltran WF, Vollmers S, et al
    HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells.
    PLoS Pathog. 2022;18:e1010572.
    PubMed     Abstract available
    
    
    May 2022
79. HAN M, Cantaloube-Ferrieu V, Xie M, Armani-Tourret M, et al
    HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages.
    PLoS Pathog. 2022;18:e1010335.
    PubMed     Abstract available
    
    
    
80. SCHAPIRO HM, Khasnis MD, Ahn K, Karagiaridi A, et al
    Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.
    PLoS Pathog. 2022;18:e1010531.
    PubMed     Abstract available
    
    
    
81. BRADLEY F, Franzen Boger M, Kaldhusdal V, Ahlberg A, et al
    Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate.
    PLoS Pathog. 2022;18:e1010494.
    PubMed     Abstract available
    
    
    
82. WELBOURN S, Chakraborty S, Yang JE, Gleinich AS, et al
    A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.
    PLoS Pathog. 2022;18:e1010488.
    PubMed     Abstract available
    
    
    April 2022
83. HINGANKAR N, Deshpande S, Das P, Rizvi ZA, et al
    A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
    PLoS Pathog. 2022;18:e1010465.
    PubMed     Abstract available
    
    
    
84. MOLDT B, Chandrashekar A, Borducchi EN, Nkolola JP, et al
    HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
    PLoS Pathog. 2022;18:e1010467.
    PubMed     Abstract available
    
    
    March 2022
85. JURCZYSZAK D, Manganaro L, Buta S, Gruber C, et al
    ISG15 deficiency restricts HIV-1 infection.
    PLoS Pathog. 2022;18:e1010405.
    PubMed     Abstract available
    
    
    
86. LEWITUS E, Townsley SM, Li Y, Donofrio GC, et al
    HIV-1 infections with multiple founders associate with the development of neutralization breadth.
    PLoS Pathog. 2022;18:e1010369.
    PubMed     Abstract available
    
    
    
87. BARBIAN HJ, Seaton MS, Narasipura SD, Wallace J, et al
    beta-catenin regulates HIV latency and modulates HIV reactivation.
    PLoS Pathog. 2022;18:e1010354.
    PubMed     Abstract available
    
    
    
88. JAMES A, Dixit NM
    Transmitted HIV-1 is more virulent in heterosexual individuals than men-who-have-sex-with-men.
    PLoS Pathog. 2022;18:e1010319.
    PubMed     Abstract available
    
    
    
89. ORTEGA-GONZALEZ P, Taylor G, Jangra RK, Tenorio R, et al
    Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis.
    PLoS Pathog. 2022;18:e1010322.
    PubMed     Abstract available
    
    
    
90. SHAHBAZ S, Okoye I, Blevins G, Elahi S, et al
    Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals.
    PLoS Pathog. 2022;18:e1010378.
    PubMed     Abstract available
    
    
    
91. CHANG XL, Reed JS, Webb GM, Wu HL, et al
    Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
    PLoS Pathog. 2022;18:e1010396.
    PubMed     Abstract available
    
    
    February 2022
92. XUE G, Braczyk K, Goncalves-Carneiro D, Dawidziak DM, et al
    Poly(ADP-ribose) potentiates ZAP antiviral activity.
    PLoS Pathog. 2022;18:e1009202.
    PubMed     Abstract available
    
    
    
93. PAMPUSCH MS, Abdelaal HM, Cartwright EK, Molden JS, et al
    CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.
    PLoS Pathog. 2022;18:e1009831.
    PubMed     Abstract available
    
    
    
94. STROEHLEIN AJ, Korhonen PK, Lee VV, Ralph SA, et al
    Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variation.
    PLoS Pathog. 2022;18:e1010288.
    PubMed     Abstract available
    
    
    January 2022
95. OKOYE AA, Fromentin R, Takata H, Brehm JH, et al
    The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription.
    PLoS Pathog. 2022;18:e1010245.
    PubMed     Abstract available
    
    
    
96. GRAU-EXPOSITO J, Perea D, Suppi M, Massana N, et al
    Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
    PLoS Pathog. 2022;18:e1010171.
    PubMed     Abstract available
    
    
    
97. HIOE CE, Li G, Liu X, Tsahouridis O, et al
    Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice.
    PLoS Pathog. 2022;18:e1010183.
    PubMed     Abstract available
    
    
    
98. MOHAMMADI A, Bagherichimeh S, Choi Y, Fazel A, et al
    Insertive condom-protected and condomless vaginal sex both have a profound impact on the penile immune correlates of HIV susceptibility.
    PLoS Pathog. 2022;18:e1009948.
    PubMed     Abstract available
    
    
    
99. DASKOU M, Mu W, Sharma M, Vasilopoulos H, et al
    ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV.
    PLoS Pathog. 2022;18:e1010160.
    PubMed     Abstract available
    
    
    
100. ZHUKOVA A, Voznica J, Felipe MD, To TH, et al
     Correction: Cuban history of CRF19 recombinant subtype of HIV-1.
     PLoS Pathog. 2022;18:e1010224.
     PubMed     Abstract available
     
     
     December 2021
101. KUNIHOLM J, Armstrong E, Bernabe B, Coote C, et al
     Intragenic proviral elements support transcription of defective HIV-1 proviruses.
     PLoS Pathog. 2021;17:e1009982.
     PubMed     Abstract available
     
     
     
102. MELTON A, Doyle-Meyers LA, Blair RV, Midkiff C, et al
     The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease.
     PLoS Pathog. 2021;17:e1010162.
     PubMed     Abstract available
     
     
     
103. MURRAY JM
     Dynamics of latent HIV under clonal expansion.
     PLoS Pathog. 2021;17:e1010165.
     PubMed     Abstract available
     
     
     
104. SHARMA V, Creegan M, Tokarev A, Hsu D, et al
     Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
     PLoS Pathog. 2021;17:e1010105.
     PubMed     Abstract available
     
     
     
105. RIVERA-CUEVAS Y, Mayoral J, Di Cristina M, Lawrence AE, et al
     Toxoplasma gondii exploits the host ESCRT machinery for parasite uptake of host cytosolic proteins.
     PLoS Pathog. 2021;17:e1010138.
     PubMed     Abstract available
     
     
     
106. OLBRICH L, Stockdale L, Basu Roy R, Song R, et al
     Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.
     PLoS Pathog. 2021;17:e1010061.
     PubMed     Abstract available
     
     
     
107. ZILA V, Muller TG, Muller B, Krausslich HG, et al
     HIV-1 capsid is the key orchestrator of early viral replication.
     PLoS Pathog. 2021;17:e1010109.
     PubMed    
     
     
     November 2021
108. FISCHINGER S, Cizmeci D, Deng D, Grant SP, et al
     Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
     PLoS Pathog. 2021;17:e1010016.
     PubMed     Abstract available
     
     
     
109. STONEHAM CA, Langer S, De Jesus PD, Wozniak JM, et al
     A combined EM and proteomic analysis places HIV-1 Vpu at the crossroads of retromer and ESCRT complexes: PTPN23 is a Vpu-cofactor.
     PLoS Pathog. 2021;17:e1009409.
     PubMed     Abstract available
     
     
     
110. TAYLOR RA, McRaven MD, Carias AM, Anderson MR, et al
     Localization of infection in neonatal rhesus macaques after oral viral challenge.
     PLoS Pathog. 2021;17:e1009855.
     PubMed     Abstract available
     
     
     
111. ADRIANO VIEIRA V, Adland E, Malone DFG, Martin MP, et al
     An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
     PLoS Pathog. 2021;17:e1010090.
     PubMed     Abstract available
     
     
     
112. ZHAO Z, Fagerlund R, Tossavainen H, Hopfensperger K, et al
     Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineage.
     PLoS Pathog. 2021;17:e1009728.
     PubMed     Abstract available
     
     
     
113. MIELKE D, Bandawe G, Zheng J, Jones J, et al
     ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
     PLoS Pathog. 2021;17:e1010046.
     PubMed     Abstract available
     
     
     
114. ADENIJI OS, Kuri-Cervantes L, Yu C, Xu Z, et al
     Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
     PLoS Pathog. 2021;17:e1010034.
     PubMed     Abstract available
     
     
     October 2021
115. MARTIN MM, Matkovic R, Larrous P, Morel M, et al
     Binding to DCAF1 distinguishes TASOR and SAMHD1 degradation by HIV-2 Vpx.
     PLoS Pathog. 2021;17:e1009609.
     PubMed     Abstract available
     
     
     
116. KMIEC D, Lista MJ, Ficarelli M, Swanson CM, et al
     S-farnesylation is essential for antiviral activity of the long ZAP isoform against RNA viruses with diverse replication strategies.
     PLoS Pathog. 2021;17:e1009726.
     PubMed     Abstract available
     
     
     
117. CROOKS ET, Almanza F, D'Addabbo A, Duggan E, et al
     Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
     PLoS Pathog. 2021;17:e1009807.
     PubMed     Abstract available
     
     
     
118. NGUYEN K, Dobrowolski C, Shukla M, Cho WK, et al
     Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
     PLoS Pathog. 2021;17:e1010014.
     PubMed     Abstract available
     
     
     August 2021
119. BANCHENKO S, Krupp F, Gotthold C, Burger J, et al
     Structural insights into Cullin4-RING ubiquitin ligase remodelling by Vpr from simian immunodeficiency viruses.
     PLoS Pathog. 2021;17:e1009775.
     PubMed     Abstract available
     
     
     July 2021
120. BISWAS A, Zhou D, Fiches GN, Wu Z, et al
     Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.
     PLoS Pathog. 2021;17:e1009764.
     PubMed     Abstract available
     
     
     
121. KERVEVAN J, Bouteau A, Lanza JS, Hammoudi A, et al
     Targeting human langerin promotes HIV-1 specific humoral immune responses.
     PLoS Pathog. 2021;17:e1009749.
     PubMed     Abstract available
     
     
     
122. WEN J, Cheever T, Wang L, Wu D, et al
     Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.
     PLoS Pathog. 2021;17:e1009738.
     PubMed     Abstract available
     
     
     
123. CHAKHTOURA M, Fang M, Cubas R, O'Connor MH, et al
     Germinal Center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signaling.
     PLoS Pathog. 2021;17:e1009732.
     PubMed     Abstract available
     
     
     
124. BARRENAS F, Hansen SG, Law L, Driscoll C, et al
     Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
     PLoS Pathog. 2021;17:e1009278.
     PubMed     Abstract available
     
     
     May 2021
125. BOCHART RM, Busman-Sahay K, Bondoc S, Morrow DW, et al
     Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
     PLoS Pathog. 2021;17:e1009565.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.